Annals of Oncology Advance Access originally published online on May 25, 2008
Annals of Oncology 2008 19(8):1509; doi:10.1093/annonc/mdn371
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
letters to the editors |
Does oxaliplatin and paclitaxel combination show an activity of some extent in pretreated patients with germ-cell tumors?
Reply to the article "A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors" by C. Theodore et al. (Ann Oncol 2008; doi: 10.1093/annonc/mdn122)
| The first 10% of the full text of this article appears below. |
We have read with interest the article by Theodore et al. on the results of a combination of oxaliplatin and paclitaxel in a population of pretreated patients (pts) with
1 Department of Medicine, Medical Oncology Unit 3
2 Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
* (E-mail: anynecchi@yahoo.it)